Aion Therapeutic Inc (TSE:AION) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Aion Therapeutic Inc. has been granted a Management Cease Trade Order by the BCSC, which gives them until October 28, 2024, to file necessary financial disclosures following the acquisition of Toppen Health. The company is working diligently to provide valuations and impairment tests required for the audit of its annual financial statements, and intends to meet the new deadline while issuing bi-weekly updates.
For further insights into TSE:AION stock, check out TipRanks’ Stock Analysis page.